Mubadala Launches its Latest National Champion – 'Mubadala Bio' to Transform Life Sciences in the UAE and Beyond
Mubadala Bio's integrated portfolio includes 10 facilities spans across Asia, Africa and Europe (with 6 located within the Emirates), serving over 100 countries. Across these sites, the cumulative manufacturing capacity of its facilities exceeds 2.5 billion tablets and capsules, 120 million IVs and injectables annually, and spans 110,000 square meters – enabling the production and global distribution of more than 10,000 products. Mubadala Bio's portfolio focuses on key therapy areas that address some of the world's most pressing health needs, supporting the full continuum of care, from prevention and diagnosis to treatment, ongoing support, and complementary medicine. By forging long-term strategic partnerships with global industry leaders and top-tier academic institutions, Mubadala Bio is accelerating biopharma innovation and local manufacturing, cultivating world-class talent and driving accelerated advancements. This holistic strategy spans the full continuum of care by providing integrated disease solutions across prevention, diagnostics, treatment, supportive treatment, and complementary medicine.
Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala's UAE Investments Platform, said: 'By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi's role in delivering impactful health solutions on a global scale. Through our National Champions, we continue our efforts to accelerate the UAE's economic diversification by investing in priority sectors and support building a knowledge-based economy.
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, added: 'With the launch of Mubadala Bio, we are proud to take a significant step forward in supporting the UAE's ambition to be a global leader in the life sciences industry. By focusing on local manufacturing and enhancing our distribution and logistics capabilities, we are building a more resilient and self-sustaining life sciences sector, one that responds to today's needs while preparing for tomorrow's challenges.'
Focusing on integrated biopharma and pharma logistics, Mubadala Bio aims to support the UAE's Centennial 2071 vision. As part of its launch, it will mark its first physical presence at Make it in the Emirates 2025, showcasing the UAE's success in building a competitive life sciences industry and reinforcing its position as a hub for innovation and local manufacturing.
For more information about Mubadala Bio and its initiatives, please visit mubadalabio.ae
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
6 hours ago
- Al Etihad
Aldar delivers Dh4.1 billion net profit in H1 2025
29 July 2025 10:38 ABU DHABI (ALETIHAD)Aldar delivered strong earnings in the first half of 2025, reporting a 24% year-on-year increase in net profit to Dh4.1 billion, driven by robust revenue recognition from a healthy development backlog and continued expansion across its investment results for the first half and the second quarter of the year were posted on the website of Abu Dhabi Securities Exchange (ADX). Aldar, which is an ADX-listed realty company with market capitalisation of Dh77.84 billion, is backed by Mubadala and Alpha Dhabi. Profit before tax rose 35% to Dh4.7 billion, while EBITDA increased 38% year-on-year to Dh5.3 billion. Revenues for the period surged 42% to Dh15.5 billion, reflecting strong development sales and contributions from recently acquired income-generating development sales reached Dh18.3 billion, up 31% from a year earlier, underpinned by five new project launches in the UAE. The revenue backlog climbed to a record Dh62.3 billion, with Dh53.4 billion attributed to UAE-based projects. Notably, international buyers and expatriate residents accounted for Dh14.7 billion—or 84%—of total UAE development sales, highlighting sustained foreign investor interest in the local of the standout moments came in July when Aldar sold a luxury mansion at Faya Al Saadiyat for a record Dh400 million, reflecting the strength of Abu Dhabi's high-end segment and growing investment from ultra-high-net-worth individuals. Further signalling increased institutional interest, a residential building in Mamsha Gardens was sold to Hong Kong's GAW Capital for Dh586 investment platform continued its expansion, with adjusted EBITDA rising 18% to Dh1.6 billion in H1. Commercial and residential assets in Masdar City acquired through the Mubadala partnership made a significant contribution. The group also expanded its logistics portfolio with the Dh530 million acquisition of income-generating warehousing and light industrial assets at ALMARKAZ Industrial Park in Abu Aldar Education advanced its offering with a strategic partnership with King's College School Wimbledon to develop a premium K–12 campus on Fahid remains strong with Dh12.2 billion in free cash and Dh17.5 billion in undrawn credit facilities. Assets under management reached Dh47 billion as of H.E. Mohamed Khalifa Al Mubarak said: "Aldar delivered exceptional first-half earnings growth driven by the continued strength of our diversified business model and disciplined strategy execution. The UAE's rising population and its growing appeal as a global centre for business, talent, and lifestyle are driving significant demand for high-quality real estate — propelling our H1 development sales to Dh18.3 billion and backlog to a record Dh62.3 billion."Group Chief Executive Officer Talal Al Dhiyebi said: 'Our development business recorded high demand across existing inventory and launches, with standout sales at flagship projects in Abu Dhabi and Dubai. Aldar Investment continues to deliver solid income growth, supported by high occupancy, rising rental rates, and recent acquisitions. We continue to scale and diversify the platform through expansion in the core sectors of retail, residential, hospitality, commercial and logistics.' Aldar also made progress in sustainability, receiving an upgrade in its MSCI ESG rating from 'BBB' to 'A', and inclusion in the FTSE4Good Index Series, reinforcing its commitment to responsible investment and long-term value creation. Source: Aletihad - Abu Dhabi
The National
5 days ago
- The National
Mubadala hosts business leaders on sidelines of DC Open in Washington
Abu Dhabi's strategic investment firm Mubadala has co-hosted a business convening with the Milken Institute and Citi on the sidelines of the Mubadala Citi DC Open in Washington. Speakers at the event were Mubadala deputy group chief executive Homaid Al Shimmari, US Commerce Secretary Howard Lutnick, G42 group chief global affairs officer Talal Al Kaissi, MGX chief strategy and safety officer David Scott, Milken Institute chairman Michael Milken, Washington Mayor Muriel Bowser, US tennis star Frances Tiafoe and others. Among the topics discussed during the Tuesday event included investment and policy priorities to advance economic growth. Key themes during the session included sport's role in Abu Dhabi's evolution as a global city, Mubadala's commitment to adding value and how sport is driving Washington's changing economy. Other themes included US facilitating foreign investment in the UAE, Mubadala's role as a key player in the Emirates' economic partnership with the US and the two countries' relationship in AI and artificial intelligence. The US and UAE have strengthened their relationship in the new technology in recent months, including the UAE's commitment to a $1.4 trillion investment framework in the US related to AI infrastructure, semiconductors, energy and manufacturing. In May, UAE President Sheikh Mohamed and Mr Trump witnessed the unveiling of plans for a new 5GW UAE-US AI Campus in Abu Dhabi during the president's visit to the country. Mubadala became a co-sponsor of the annual tennis tournament in 2023. The tournament is a 500-level event on the ATP and WTA tours, featuring a field of 48 players in the men's singles event and 28 players in the women's singles event.
Zawya
6 days ago
- Zawya
Space42 secures $695.5mln facility to fund UAE satellites
The Abu Dhabi-listed Space42 has secured a $695.5 million Export Credit Agency (ECA)-backed financing facility to fund the development of UAE's next-generation geostationary satellites, Al Yah 4 and Al Yah 5. The AI-powered SpaceTech firm, which is backed by Abu Dhabi sovereign investor Mubadala, G42 and the International Holding Company, said the facility has been arranged by Crédit Agricole CIB, Santander CIB, Societe Generale, and Natixis and backed by Bpifrance Assurance Export. Space42 said the facility will provide long-term financing that is aligned with its satellite development timeline, whilst strengthening its liquidity position to support future growth. The Al Yah 4 and Al Yah 5 programme is underpinned by a 17-year, $5.1 billion government contract commencing in 2026, with the satellites scheduled for launch in 2027 and 2028. Space42 debuted on the Abu Dhabi Securities Exchange (ADX) in October following the merger of Bayanat and Al Yah Satellite Communications Company (Yahsat).
